RecruitingNCT04905537

Study on Early Genetic Screening and Precise Strategy of Neonatal Critical Illness

Sponsor

Children's Hospital of Fudan University

Enrollment

4,000 participants

Start Date

Jan 1, 2021

Study Type

OBSERVATIONAL

Conditions

Stillbirth Newborn Hereditary Disease Genetic Screening

Summary

The researchers hope to establish an overall program of early genetic screening for neonatal critical illness in China, and to develop precise intervention strategies to assist clinical diagnosis and treatment of hereditary critical illness.

Eligibility

Max Age: 100 Days

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying No intervention for people with genetic screening, hereditary disease, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include up to age 100 Days.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention

It's only observational study. No interventions.

Locations(1)

Children's Hospital of Fudan University

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04905537

Related Trials

Walk With Me (WWM) for Perinatal Grief

NCT070119402 locations

The Effect of Pre-Breastfeeding Breathing Exercises on Maternal Anxiety, Well-being, and Infant Stress in Mothers Whose Infants Are in the Neonatal Intensive Care Unit

NCT076344451 location